Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spinal Muscular Atrophies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07712198
What this trial is testing

Al Prediction of Sarcopenia Risk in Neurocritical ICU Patients

Who this might be right for
Intracerebral HemorrhageSubarachnoid HemorrhageSubdural Hematoma+3 more
Trabzon Kanuni Education and Research Hospital 72
Not applicableUnknownNCT02227407
What this trial is testing

Reciprocating Gait Orthoses for Paraplegia Patients

Who this might be right for
MyelomeningoceleSpinal Cord InjurySpinal Muscular Atrophy
National Taiwan University Hospital 8
Not applicableStudy completedNCT00080600
What this trial is testing

Brain Physiology in Polio Survivors

Who this might be right for
Postpoliomyelitis
National Institute of Neurological Disorders and Stroke (NINDS) 90
Not applicableLooking for participantsNCT05644522
What this trial is testing

Nomad P-KAFO Study

Who this might be right for
Cerebrovascular AccidentPost-polio SyndromeSpinal Cord Injuries+3 more
Shirley Ryan AbilityLab 36
Not applicableLooking for participantsNCT07531719
What this trial is testing

Risdiplam in Participants With Type I and Type II Spinal Muscle Atrophy (SMA)

Who this might be right for
Spinal Muscle Atrophy
Hoffmann-La Roche 30
Testing effectiveness (Phase 2)Ended earlyNCT02348281
What this trial is testing

Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients

Who this might be right for
Breast Cancer
Fudan University 1
Not applicableStudy completedNCT04444739
What this trial is testing

Association Between Lumbar Muscle Atrophy, Sagittal Pelvic Alignment and Stenosis Grade in Patients With Degenerative Lumbar Spinal Stenosis

Who this might be right for
Lumbar Spinal Stenosis (LSS)
University Hospital, Basel, Switzerland 165
Testing effectiveness (Phase 2)Ended earlyNCT03819660
What this trial is testing

Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3

Who this might be right for
Spinal Muscular Atrophy Type 3
Catalyst Pharmaceuticals, Inc. 13
Not applicableStudy completedNCT04907162
What this trial is testing

Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

Who this might be right for
Pompe Disease (Late-onset)Myotonic Dystrophy Type 1 (DM1)Myotonic Dystrophy Type 2+4 more
LMU Klinikum 82
Not applicableStudy completedNCT01233817
What this trial is testing

Progressive Strength Training in Spinal Muscular Atrophy

Who this might be right for
Muscular Atrophy, Spinal
University of Utah 12
Not applicableLooking for participantsNCT03698149
What this trial is testing

ECoG BMI for Motor and Speech Control

Who this might be right for
ALSSCI - Spinal Cord InjuryStroke+2 more
Karunesh Ganguly 3
Testing effectiveness (Phase 2)Looking for participantsNCT07047144
What this trial is testing

Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular AtrophySMASpinal Muscular Atrophy Type 2+3 more
Scholar Rock, Inc. 52
Not applicableUnknownNCT05760209
What this trial is testing

SMN Circular RNAs as Potential New Targets and Biomarkers for SMA

Who this might be right for
Spinal Muscular Atrophy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 30
Large-scale testing (Phase 3)Study completedNCT05156320
What this trial is testing

Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam

Who this might be right for
Spinal Muscular AtrophySpinal Muscular Atrophy Type 3Spinal Muscular Atrophy Type 2+7 more
Scholar Rock, Inc. 188
Testing effectiveness (Phase 2)Ended earlyNCT02462759
What this trial is testing

Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA).

Who this might be right for
Spinal Muscular Atrophy
Biogen 21
Not applicableNot Yet RecruitingNCT07822711
What this trial is testing

Effects of Different Stiffness Settings During Robotic Isokinetic Training in Children With SMA

Who this might be right for
Spinal Muscular Atrophy (SMA)
Peking University Third Hospital 13
Not applicableLooking for participantsNCT07521930
What this trial is testing

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

Who this might be right for
Tetraplegia/TetraparesisAmyotrophic Lateral Sclerosis (ALS)Muscular Disorders, Atrophic+6 more
Johns Hopkins University 5
Not applicableStudy completedNCT03319264
What this trial is testing

Sarcopenia in Axial and Peripheral Spondyloarthropathies

Who this might be right for
SpondylarthropathySarcopenia
Hospices Civils de Lyon 106
Testing effectiveness (Phase 2)Study completedNCT00365599
What this trial is testing

Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 43
Not applicableLooking for participantsNCT07478172
What this trial is testing

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Who this might be right for
Neuromuscular Diseases (NMD)Amyotrophic Lateral SclerosisMyasthenia Gravis+15 more
University of Missouri-Columbia 50
Next Page